Table 2 Unadjusted secondary outcomes
Outcome | Linezolid (n = 101) | Vancomycin (n = 87) | P value |
|---|---|---|---|
Mortality, n (%) | 10 (9.9) | 8 (9.2) | 1.00 |
Thrombocytopenia, n (%) | 18 (17.8) | 16 (18.4) | 1.00 |
Anemia, n (%) | 43 (42.6) | 41 (47.1) | 0.559 |
Nephrotoxicity, n (%) | 11 (10.9) | 13 (14.9) | 0.541 |
Days on mechanical ventilation, median (IQR) | 11 (14) | 13 (11.5) | 0.276 |
Length of stay in the ICU, median (IQR) | 11 (14) | 13 (11.5) | 0.823 |
Length of stay in the hospital, median (IQR) | 18 (19) | 16 (14.5) | 0.773 |